
Join to View Full Profile
1959 Ne Pacific StBox 357110Seattle, WA 98195
Phone+1 205-598-6131
Fax+1 206-598-6189
Are you Dr. Salipante?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen Salipante, MD is a board certified pathologist in Seattle, Washington. He is currently licensed to practice medicine in Washington.
Education & Training
- University of WashingtonResidency, Pathology-Anatomic and Clinical, 2011 - 2014
- University of Washington School of Medicine
Certifications & Licensure
- WA State Medical License 2011 - 2027
- WA State Medical License 2013 - 2027
- American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin...Brian J Werth, Rutan Zhang, Ismael A Barreras Beltran, Kelsi Penewit, Adam Waalkes
The Journal of Antimicrobial Chemotherapy. 2025-04-02 - 1 citationsDNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1T-Lineage Cancers.Ian I Cardle, Jai Raman, Dinh Chuong Nguyen, Tong Wang, Abe Y Wu
ACS Applied Materials & Interfaces. 2025-01-22 - 1 citationsMechanisms ofsurvival of trimethoprim-sulfamethoxazole-induced thymineless death.Lauren J Gonsalves, Allyson Tran, Tessa Gardiner, Tiia Freeman, Angshita Dutta
Mbio. 2024-11-13
Press Mentions
- NIH Funds 3 Syphilis Diagnostics ProjectsSeptember 19th, 2024
- Detecting Myeloid Malignancy Minimal Residual DiseaseOctober 19th, 2021
- ‘Scary Situation’—Lab Leaders on Staffing and COVIDOctober 19th, 2021
Grant Support
- Rapid and Ultrasensitive aptamer-based detection technologies for T. pallidumUNIVERSITY OF WASHINGTON2024–2026
- Efficient, cost-effective, and ultrasensitive sequencing of somatic mutationsUNIVERSITY OF WASHINGTON2022–2025